Managers / Q2 2020 · view latest →
Aufman Associates Inc
CIK 0001801573 · 2200 GEORGETOWN DR, SUITE 401, SEWICKLEY, PA, 15143 · 7249345600
Summary
Aufman Associates Inc reported $88M in U.S.-listed holdings across 35 positions for Q2 2020.
The portfolio is heavily concentrated: Vanguard Small Cap Index Etf alone accounts for 26.8% of reported value.
Compared with Q1 2020, the fund opened 4 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 74.2% · $65M
- Common Stock · 19.0% · $17M
- Other · 6.5% · $6M
- ADR · 0.4% · $311,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| PNCPNC Financial Services | NEW | +4.8K | 4.8K | +$501,000 | $501,000 |
| LOWLowe's Companies | NEW | +1.7K | 1.7K | +$227,000 | $227,000 |
| COPConocoPhillips | NEW | +5.3K | 5.3K | +$225,000 | $225,000 |
| IBMIBM | NEW | +1.7K | 1.7K | +$211,000 | $211,000 |
| PKNPerkinElmer | ADDED | +6.1K | 11.7K | +$725,000 | $1M |
| TMOThermo Fisher Scientific | SOLD OUT | −1.0K | 0 | −$286,000 | $0 |
| BRK/ABerkshire Hathaway Cl A | SOLD OUT | −1 | 0 | −$272,000 | $0 |
| NEENextEra Energy | SOLD OUT | −1.1K | 0 | −$272,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $204M | 65 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $195M | 67 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $178M | 66 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $162M | 64 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $145M | 57 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $148M | 59 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $156M | 64 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $140M | 46 | Aug 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $142M | 46 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $133M | 43 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $119M | 43 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $121M | 43 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $117M | 42 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $108M | 43 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $95M | 40 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $105M | 44 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $127M | 47 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $135M | 54 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $122M | 46 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $130M | 49 | Aug 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $120M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $111M | 43 | Feb 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $93M | 37 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $88M | 35 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $72M | 35 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $97M | 42 | Feb 6, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.